The present invention relates to pharmaceutical compositions and more particularly to a pharmaceutical composition containing the compound {1S-[1α, 2α, 3β (1S*,2R*),5β]}-3-(7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol.本發明係關於醫藥組合物,且更特定言之係關於含有化合物{1S-[1α,2α,3β(1S*,2R*),5β]}-3-(7-{[2-(3,4-二氟苯基)環丙基]胺基}-5-(丙基硫基)-3H-1,2,3-三唑幷[4,5-d]嘧啶-3-基)-5-(2-羥基乙氧基)環戊烷-1,2-二醇之醫藥組合物。